Giovanni Amodeo
Impact in
- Biological Psychiatry top 10%
- Tryptophan and brain disorders
-
- Schizophrenia research and treatment
- Bipolar Disorder and Treatment
Papers in
-
- Attention Deficit Hyperactivity Disorder 3
- Bipolar Disorder and Treatment 2
- Electroconvulsive Therapy Studies 2
- Schizophrenia research and treatment 2
-
- Obsessive-Compulsive Spectrum Disorders 2
- Co-authors
- Andrea Fagiolini (13 shared papers)Paola Rocca (1 shared paper)Edoardo Spina (1 shared paper)Letizia Bossini (1 shared paper)Mario Amore (1 shared paper)Anna Coluccia (1 shared paper)Ilaria Casolaro (1 shared paper)Riccardo De Giorgi (1 shared paper)
- Journals
- European Neuropsychopharmacology (3 papers)Expert Opinion on Pharmacotherapy (2 papers)Expert Opinion on Drug Safety (1 paper)CNS & Neurological Disorders - Drug Targets (1 paper)Current Pharmaceutical Design (1 paper)
- Partner nations
- ItalyUnited StatesSpain
In The Last Decade
Giovanni Amodeo
11 papers receiving 164 citations
Peers
Comparison fields: 5 of 60
- Biological Psychiatry 42
- Psychiatry and Mental health 77
- Behavioral Neuroscience 18
- Experimental and Cognitive Psychology 28
- Pharmacology 35
Countries citing papers authored by Giovanni Amodeo
This map shows the geographic impact of Giovanni Amodeo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giovanni Amodeo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giovanni Amodeo more than expected).
Fields of papers citing papers by Giovanni Amodeo
This network shows the impact of papers produced by Giovanni Amodeo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giovanni Amodeo. The network helps show where Giovanni Amodeo may publish in the future.
Co-authors
The 25 scholars most cited alongside Giovanni Amodeo, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2015 | 43 | |
| 2 | 2017 | 41 | |
| 3 | 2016 | 33 | |
| 4 | 2019 | 13 | |
| 5 | 2018 | 10 | |
| 6 | 2016 | 10 | |
| 7 | 2020 | 8 | |
| 8 | 2017 | 6 | |
| 9 | 2016 | 4 | |
| 10 | 2016 | 3 | |
| 11 | Varicocele and puberty. A transversal and longitudinal survey. | 1989 | 1 |
| 12 | 2022 | 0 | |
| 13 | 2017 | 0 | |
| 14 | 2015 | 0 | |
| 15 | 2019 | 0 |
About Giovanni Amodeo
Giovanni Amodeo is a scholar working on Psychiatry and Mental health, Clinical Psychology, Pharmacology, Pediatrics, Perinatology and Child Health and Public Health, Environmental and Occupational Health, having authored 15 papers that have together received 172 indexed citations. Recurring topics across this work include Attention Deficit Hyperactivity Disorder (3 papers), Treatment of Major Depression (3 papers), Pharmacological Effects and Toxicity Studies (2 papers), Bipolar Disorder and Treatment (2 papers), Obsessive-Compulsive Spectrum Disorders (2 papers), Electroconvulsive Therapy Studies (2 papers), Schizophrenia research and treatment (2 papers) and Maternal Mental Health During Pregnancy and Postpartum (2 papers). The work is most often cited by research in Biological Psychiatry (42 citations), Psychiatry and Mental health (77 citations), Behavioral Neuroscience (18 citations), Experimental and Cognitive Psychology (28 citations) and Pharmacology (35 citations). Giovanni Amodeo has collaborated with scholars based in Italy, United States and Spain. Frequent co-authors include Andrea Fagiolini, Paola Rocca, Edoardo Spina, Letizia Bossini, Mario Amore, Anna Coluccia, Ilaria Casolaro, Riccardo De Giorgi, Alessandro Cuomo and Andreas Erfurth. Their work appears in journals such as European Neuropsychopharmacology, Expert Opinion on Pharmacotherapy, Expert Opinion on Drug Safety, CNS & Neurological Disorders - Drug Targets and Current Pharmaceutical Design.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.